Curex Life Science Fund, LP
Amendment
CIK: 0001789886·Pooled Investment Fund·DELAWARE·Filed: Nov 24, 2025
Total Offering
N/A
Amount Sold
$10,175,395
Investors
34
First Sale
Dec 3, 2019
Offering Details
- Type
- Equity, Pooled Investment Fund
- Exemptions
- Rule 506(b), Section 3(c), Section 3(c)(1)
Related Persons
| Name | Role |
|---|---|
| Joshua Trantum | Executive Officer, Director, Promoter |
| Keith Ferrari | Executive Officer, Promoter |
Company
SEC Filing
0001789886-25-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free